UDK: 616.831.-005.1-06:616.89-008.454-085.214.2

APPLICATION OF THE PRODUCT OF ULTRA SMALL DOSES OF ANTIBODIES TO S-100 PROTEIN AND NO-SYNTHESIS IN ISCHEMIC STROKE

O.S. Golovina, E.V. Eliseeva, O.V. Perelomova, P.P. Kalinskij, D.P. Kalinskij

ФГБОУ ВО «Тихоокеанский государственный медицинский университет» Министерства здравоохранения Российской Федерации

Abstract

In an open, randomized comparative clinical study, the effectiveness of a drug containing antibodies to the brain-specific protein S-100 and endothelial nitroxidine synthase (NO-synthase) in patients in the early recovery period of ischemic stroke for 12 weeks was studied, the average age of the patients was 59,7 ± 7,69 years old. The neuropsychological examination included the following Hospital Anxiety and Depression Scale (HADS).

Keywords

early recovery period, ischemic stroke, depression, neurological deficiency, antibodies to the brain-specific protein S-100 and endothelial NO-synthase, pharmacological correction.

Contacts

Головина Олеся Сергеевна – аспирант кафедры общей и клинической фармакологии, Тихоокеанский государственный медицинский университет, e-mail: Olesya0801@yandex.ru